Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

On launching the new OPEN ARMS PPI group in Oxford, Dr. Laura Coates explored the patient and public involvement (PPI) models of three academic centres in the UK to show how it benefits researchers, clinicians, and patients alike.

Laura Coates

It has been shown beyond doubt that involving patients and the public in research provides long term benefits, promoting higher standards of research and improved patient outcomes. Patient participation, and patient engagement are important facets of patient-centred research. Patient involvement (PPI), as defined by INVOLVE, a national advisory group funded by the National Institute for Health Research (NIHR), is 'research being carried out 'with' or 'by' members of the public rather than 'to'.

It's this involvement that has positively influenced the research process; from the initial stages of research with the development of research questions, research design and delivery, data collection and analysis, through to dissemination.

PPI is particularly crucial in rheumatology research, as most rheumatic and musculoskeletal conditions are life-long and life-altering. So how should PPI be undertaken to ensure consistency, quality, and represent patients from a range of demographics to ensure that the research represents the wider community?

In 2020, the Oxford Patient Engagement Network in Arthritis and Musculoskeletal Science (OPEN ARMS) group was launched at NDORMS. Leading the launch, Dr Laura Coates drew on the experience of other established groups in the UK.

NIHR Leeds Biomedical Research Centre

The NIHR Leeds Biomedical Research Centre has over 250 people comprising patients, carers, and members of the public. Alongside bi-monthly meetings, task and finish working groups, the group supports activities to involve under-represented groups and promote diversity within its patient community.

University College London (UCL)

UCL has developed a model of a core patient and public involvement cohort representing various rheumatic conditions who will provide input during virtual meetings, with discussion around research project development and priority setting. Patient-facing literature and other research documentation is written in language that is understandable to the general public.

Oxford Biomedical Research Centre

The Oxford Biomedical Research Centre runs a large and successful advisory group overseeing patient and public involvement across all specialities. OPEN ARMS launched within the musculoskeletal theme aiming to focus on diversity and gain representation from previously harder to reach groups through carefully designed recruitment materials and extensive outreach to different community groups.

The groups faced different challenges through the Covid pandemic. The move to virtual platforms may have had an adverse impact on participation from under-represented groups with lower technology proficiency. For others, online meetings may have appealed to the younger demographics.

The challenge will be to adapt activities to remain inclusive to all patient communities while continuing to apply innovative thinking to develop dynamic, impactful collaborations with patients that also benefit researchers and clinicians.

Read the full paper here.

Similar stories

£1.2M to improve diagnosis of emergency spinal condition

The National Institute for Health and Care Research has awarded an Advanced Fellowship to Dr David Metcalfe to study the diagnosis of the spinal condition, cauda equina syndrome.

Professor Chris Lavy appointed to WHO technical advisory group

Congratulations to Professor Chris Lavy, who has been appointed to the World Health Organization’s (WHO) technical advisory group for integrated clinical care for a period of two years.

Oxford receives NIHR funding to test anti-TNF on post operative delirium

Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.

Gene variant links trigger finger and carpal tunnel syndrome

A new NDORMS study, published in The Lancet Rheumatology, has found a genetic variant that increases the risk of both carpal tunnel syndrome and trigger finger, and opens the door for new therapies that involve blocking the IGF-1 pathway.

Kennedy programmes support early career researchers

Since 2013 the Kennedy Institute of Rheumatology has been running a Career Development Programme, a scheme to help early career researchers launch their own independent laboratories, and more recently the Innovator Investigator Programme to bring new technologies to core research themes.

OCTRU collaboration boosts understanding of COVID vaccine response

Working with researchers across multiple universities, the Oxford Clinical Trials Unit (OCTRU) played a key role in delivering results of the national VROOM trial (Vaccine Response On Off Methotrexate).